Global T-Cell Immunotherapy Market Growth (Status and Outlook) 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global T-Cell Immunotherapy Market Size 2017-2028

2.1.2 T-Cell Immunotherapy Market Size CAGR by Region 2017 VS 2022 VS 2028

2.2 T-Cell Immunotherapy Segment by Type

2.2.1 CAR-T

2.2.2 TCR

2.2.3 TIL Therapies

2.3 T-Cell Immunotherapy Market Size by Type

2.3.1 T-Cell Immunotherapy Market Size CAGR by Type (2017 VS 2022 VS 2028)

2.3.2 Global T-Cell Immunotherapy Market Size Market Share by Type (2017-2022)

2.4 T-Cell Immunotherapy Segment by Application

2.4.1 Stomach Cancer

2.4.2 Lung Cancer

2.4.3 Colorectal Cancer

2.4.4 Esophagus Cancer

2.4.5 Pancreatic Cancer

2.4.6 Others

2.5 T-Cell Immunotherapy Market Size by Application

2.5.1 T-Cell Immunotherapy Market Size CAGR by Application (2017 VS 2022 VS 2028)

2.5.2 Global T-Cell Immunotherapy Market Size Market Share by Application (2017-2022)

3 T-Cell Immunotherapy Market Size by Player

3.1 T-Cell Immunotherapy Market Size Market Share by Players

3.1.1 Global T-Cell Immunotherapy Revenue by Players (2020-2022)

3.1.2 Global T-Cell Immunotherapy Revenue Market Share by Players (2020-2022)

3.2 Global T-Cell Immunotherapy Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 T-Cell Immunotherapy by Regions

4.1 T-Cell Immunotherapy Market Size by Regions (2017-2022)

4.2 Americas T-Cell Immunotherapy Market Size Growth (2017-2022)

4.3 APAC T-Cell Immunotherapy Market Size Growth (2017-2022)

4.4 Europe T-Cell Immunotherapy Market Size Growth (2017-2022)

4.5 Middle East & Africa T-Cell Immunotherapy Market Size Growth (2017-2022)

5 Americas

5.1 Americas T-Cell Immunotherapy Market Size by Country (2017-2022)

5.2 Americas T-Cell Immunotherapy Market Size by Type (2017-2022)

5.3 Americas T-Cell Immunotherapy Market Size by Application (2017-2022)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC T-Cell Immunotherapy Market Size by Region (2017-2022)

6.2 APAC T-Cell Immunotherapy Market Size by Type (2017-2022)

6.3 APAC T-Cell Immunotherapy Market Size by Application (2017-2022)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe T-Cell Immunotherapy by Country (2017-2022)

7.2 Europe T-Cell Immunotherapy Market Size by Type (2017-2022)

7.3 Europe T-Cell Immunotherapy Market Size by Application (2017-2022)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa T-Cell Immunotherapy by Region (2017-2022)

8.2 Middle East & Africa T-Cell Immunotherapy Market Size by Type (2017-2022)

8.3 Middle East & Africa T-Cell Immunotherapy Market Size by Application (2017-2022)

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Global T-Cell Immunotherapy Market Forecast

10.1 Global T-Cell Immunotherapy Forecast by Regions (2023-2028)

10.1.1 Global T-Cell Immunotherapy Forecast by Regions (2023-2028)

10.1.2 Americas T-Cell Immunotherapy Forecast

10.1.3 APAC T-Cell Immunotherapy Forecast

10.1.4 Europe T-Cell Immunotherapy Forecast

10.1.5 Middle East & Africa T-Cell Immunotherapy Forecast

10.2 Americas T-Cell Immunotherapy Forecast by Country (2023-2028)

10.2.1 United States T-Cell Immunotherapy Market Forecast

10.2.2 Canada T-Cell Immunotherapy Market Forecast

10.2.3 Mexico T-Cell Immunotherapy Market Forecast

10.2.4 Brazil T-Cell Immunotherapy Market Forecast

10.3 APAC T-Cell Immunotherapy Forecast by Region (2023-2028)

10.3.1 China T-Cell Immunotherapy Market Forecast

10.3.2 Japan T-Cell Immunotherapy Market Forecast

10.3.3 Korea T-Cell Immunotherapy Market Forecast

10.3.4 Southeast Asia T-Cell Immunotherapy Market Forecast

10.3.5 India T-Cell Immunotherapy Market Forecast

10.3.6 Australia T-Cell Immunotherapy Market Forecast

10.4 Europe T-Cell Immunotherapy Forecast by Country (2023-2028)

10.4.1 Germany T-Cell Immunotherapy Market Forecast

10.4.2 France T-Cell Immunotherapy Market Forecast

10.4.3 UK T-Cell Immunotherapy Market Forecast

10.4.4 Italy T-Cell Immunotherapy Market Forecast

10.4.5 Russia T-Cell Immunotherapy Market Forecast

10.5 Middle East & Africa T-Cell Immunotherapy Forecast by Region (2023-2028)

10.5.1 Egypt T-Cell Immunotherapy Market Forecast

10.5.2 South Africa T-Cell Immunotherapy Market Forecast

10.5.3 Israel T-Cell Immunotherapy Market Forecast

10.5.4 Turkey T-Cell Immunotherapy Market Forecast

10.5.5 GCC Countries T-Cell Immunotherapy Market Forecast

10.6 Global T-Cell Immunotherapy Forecast by Type (2023-2028)

10.7 Global T-Cell Immunotherapy Forecast by Application (2023-2028)

11 Key Players Analysis

11.1 Adaptimmune

11.1.1 Adaptimmune Company Information

11.1.2 Adaptimmune T-Cell Immunotherapy Product Offered

11.1.3 Adaptimmune T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2020-2022)

11.1.4 Adaptimmune Main Business Overview

11.1.5 Adaptimmune Latest Developments

11.2 Altor Bioscience Corporation

11.2.1 Altor Bioscience Corporation Company Information

11.2.2 Altor Bioscience Corporation T-Cell Immunotherapy Product Offered

11.2.3 Altor Bioscience Corporation T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2020-2022)

11.2.4 Altor Bioscience Corporation Main Business Overview

11.2.5 Altor Bioscience Corporation Latest Developments

11.3 Cellectis

11.3.1 Cellectis Company Information

11.3.2 Cellectis T-Cell Immunotherapy Product Offered

11.3.3 Cellectis T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2020-2022)

11.3.4 Cellectis Main Business Overview

11.3.5 Cellectis Latest Developments

11.4 Juno Therapeutics

11.4.1 Juno Therapeutics Company Information

11.4.2 Juno Therapeutics T-Cell Immunotherapy Product Offered

11.4.3 Juno Therapeutics T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2020-2022)

11.4.4 Juno Therapeutics Main Business Overview

11.4.5 Juno Therapeutics Latest Developments

11.5 Kite Pharma

11.5.1 Kite Pharma Company Information

11.5.2 Kite Pharma T-Cell Immunotherapy Product Offered

11.5.3 Kite Pharma T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2020-2022)

11.5.4 Kite Pharma Main Business Overview

11.5.5 Kite Pharma Latest Developments

11.6 Novartis

11.6.1 Novartis Company Information

11.6.2 Novartis T-Cell Immunotherapy Product Offered

11.6.3 Novartis T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2020-2022)

11.6.4 Novartis Main Business Overview

11.6.5 Novartis Latest Developments

11.7 Takara Bio

11.7.1 Takara Bio Company Information

11.7.2 Takara Bio T-Cell Immunotherapy Product Offered

11.7.3 Takara Bio T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2020-2022)

11.7.4 Takara Bio Main Business Overview

11.7.5 Takara Bio Latest Developments

11.8 Unum Therapeutics

11.8.1 Unum Therapeutics Company Information

11.8.2 Unum Therapeutics T-Cell Immunotherapy Product Offered

11.8.3 Unum Therapeutics T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2020-2022)

11.8.4 Unum Therapeutics Main Business Overview

11.8.5 Unum Therapeutics Latest Developments

12 Research Findings and Conclusion

Table 1. T-Cell Immunotherapy Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)

Table 2. Major Players of CAR-T

Table 3. Major Players of TCR

Table 4. Major Players of TIL Therapies

Table 5. T-Cell Immunotherapy Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)

Table 6. Global T-Cell Immunotherapy Market Size by Type (2017-2022) & ($ Millions)

Table 7. Global T-Cell Immunotherapy Market Size Market Share by Type (2017-2022)

Table 8. T-Cell Immunotherapy Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)

Table 9. Global T-Cell Immunotherapy Market Size by Application (2017-2022) & ($ Millions)

Table 10. Global T-Cell Immunotherapy Market Size Market Share by Application (2017-2022)

Table 11. Global T-Cell Immunotherapy Revenue by Players (2020-2022) & ($ Millions)

Table 12. Global T-Cell Immunotherapy Revenue Market Share by Player (2020-2022)

Table 13. T-Cell Immunotherapy Key Players Head office and Products Offered

Table 14. T-Cell Immunotherapy Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 15. New Products and Potential Entrants

Table 16. Mergers & Acquisitions, Expansion

Table 17. Global T-Cell Immunotherapy Market Size by Regions 2017-2022 & ($ Millions)

Table 18. Global T-Cell Immunotherapy Market Size Market Share by Regions (2017-2022)

Table 19. Americas T-Cell Immunotherapy Market Size by Country (2017-2022) & ($ Millions)

Table 20. Americas T-Cell Immunotherapy Market Size Market Share by Country (2017-2022)

Table 21. Americas T-Cell Immunotherapy Market Size by Type (2017-2022) & ($ Millions)

Table 22. Americas T-Cell Immunotherapy Market Size Market Share by Type (2017-2022)

Table 23. Americas T-Cell Immunotherapy Market Size by Application (2017-2022) & ($ Millions)

Table 24. Americas T-Cell Immunotherapy Market Size Market Share by Application (2017-2022)

Table 25. APAC T-Cell Immunotherapy Market Size by Region (2017-2022) & ($ Millions)

Table 26. APAC T-Cell Immunotherapy Market Size Market Share by Region (2017-2022)

Table 27. APAC T-Cell Immunotherapy Market Size by Type (2017-2022) & ($ Millions)

Table 28. APAC T-Cell Immunotherapy Market Size Market Share by Type (2017-2022)

Table 29. APAC T-Cell Immunotherapy Market Size by Application (2017-2022) & ($ Millions)

Table 30. APAC T-Cell Immunotherapy Market Size Market Share by Application (2017-2022)

Table 31. Europe T-Cell Immunotherapy Market Size by Country (2017-2022) & ($ Millions)

Table 32. Europe T-Cell Immunotherapy Market Size Market Share by Country (2017-2022)

Table 33. Europe T-Cell Immunotherapy Market Size by Type (2017-2022) & ($ Millions)

Table 34. Europe T-Cell Immunotherapy Market Size Market Share by Type (2017-2022)

Table 35. Europe T-Cell Immunotherapy Market Size by Application (2017-2022) & ($ Millions)

Table 36. Europe T-Cell Immunotherapy Market Size Market Share by Application (2017-2022)

Table 37. Middle East & Africa T-Cell Immunotherapy Market Size by Region (2017-2022) & ($ Millions)

Table 38. Middle East & Africa T-Cell Immunotherapy Market Size Market Share by Region (2017-2022)

Table 39. Middle East & Africa T-Cell Immunotherapy Market Size by Type (2017-2022) & ($ Millions)

Table 40. Middle East & Africa T-Cell Immunotherapy Market Size Market Share by Type (2017-2022)

Table 41. Middle East & Africa T-Cell Immunotherapy Market Size by Application (2017-2022) & ($ Millions)

Table 42. Middle East & Africa T-Cell Immunotherapy Market Size Market Share by Application (2017-2022)

Table 43. Key Market Drivers & Growth Opportunities of T-Cell Immunotherapy

Table 44. Key Market Challenges & Risks of T-Cell Immunotherapy

Table 45. Key Industry Trends of T-Cell Immunotherapy

Table 46. Global T-Cell Immunotherapy Market Size Forecast by Regions (2023-2028) & ($ Millions)

Table 47. Global T-Cell Immunotherapy Market Size Market Share Forecast by Regions (2023-2028)

Table 48. Global T-Cell Immunotherapy Market Size Forecast by Type (2023-2028) & ($ Millions)

Table 49. Global T-Cell Immunotherapy Market Size Market Share Forecast by Type (2023-2028)

Table 50. Global T-Cell Immunotherapy Market Size Forecast by Application (2023-2028) & ($ Millions)

Table 51. Global T-Cell Immunotherapy Market Size Market Share Forecast by Application (2023-2028)

Table 52. Adaptimmune Details, Company Type, T-Cell Immunotherapy Area Served and Its Competitors

Table 53. Adaptimmune T-Cell Immunotherapy Product Offered

Table 54. Adaptimmune T-Cell Immunotherapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 55. Adaptimmune Main Business

Table 56. Adaptimmune Latest Developments

Table 57. Altor Bioscience Corporation Details, Company Type, T-Cell Immunotherapy Area Served and Its Competitors

Table 58. Altor Bioscience Corporation T-Cell Immunotherapy Product Offered

Table 59. Altor Bioscience Corporation Main Business

Table 60. Altor Bioscience Corporation T-Cell Immunotherapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 61. Altor Bioscience Corporation Latest Developments

Table 62. Cellectis Details, Company Type, T-Cell Immunotherapy Area Served and Its Competitors

Table 63. Cellectis T-Cell Immunotherapy Product Offered

Table 64. Cellectis Main Business

Table 65. Cellectis T-Cell Immunotherapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 66. Cellectis Latest Developments

Table 67. Juno Therapeutics Details, Company Type, T-Cell Immunotherapy Area Served and Its Competitors

Table 68. Juno Therapeutics T-Cell Immunotherapy Product Offered

Table 69. Juno Therapeutics Main Business

Table 70. Juno Therapeutics T-Cell Immunotherapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 71. Juno Therapeutics Latest Developments

Table 72. Kite Pharma Details, Company Type, T-Cell Immunotherapy Area Served and Its Competitors

Table 73. Kite Pharma T-Cell Immunotherapy Product Offered

Table 74. Kite Pharma Main Business

Table 75. Kite Pharma T-Cell Immunotherapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 76. Kite Pharma Latest Developments

Table 77. Novartis Details, Company Type, T-Cell Immunotherapy Area Served and Its Competitors

Table 78. Novartis T-Cell Immunotherapy Product Offered

Table 79. Novartis Main Business

Table 80. Novartis T-Cell Immunotherapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 81. Novartis Latest Developments

Table 82. Takara Bio Details, Company Type, T-Cell Immunotherapy Area Served and Its Competitors

Table 83. Takara Bio T-Cell Immunotherapy Product Offered

Table 84. Takara Bio Main Business

Table 85. Takara Bio T-Cell Immunotherapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 86. Takara Bio Latest Developments

Table 87. Unum Therapeutics Details, Company Type, T-Cell Immunotherapy Area Served and Its Competitors

Table 88. Unum Therapeutics T-Cell Immunotherapy Product Offered

Table 89. Unum Therapeutics Main Business

Table 90. Unum Therapeutics T-Cell Immunotherapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 91. Unum Therapeutics Latest Developments

List of Figures

Figure 1. T-Cell Immunotherapy Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global T-Cell Immunotherapy Market Size Growth Rate 2017-2028 ($ Millions)

Figure 6. Global T-Cell Immunotherapy Market Size Market Share by Type in 2021

Figure 7. T-Cell Immunotherapy in Stomach Cancer

Figure 8. Global T-Cell Immunotherapy Market: Stomach Cancer (2017-2022) & ($ Millions)

Figure 9. T-Cell Immunotherapy in Lung Cancer

Figure 10. Global T-Cell Immunotherapy Market: Lung Cancer (2017-2022) & ($ Millions)

Figure 11. T-Cell Immunotherapy in Colorectal Cancer

Figure 12. Global T-Cell Immunotherapy Market: Colorectal Cancer (2017-2022) & ($ Millions)

Figure 13. T-Cell Immunotherapy in Esophagus Cancer

Figure 14. Global T-Cell Immunotherapy Market: Esophagus Cancer (2017-2022) & ($ Millions)

Figure 15. T-Cell Immunotherapy in Pancreatic Cancer

Figure 16. Global T-Cell Immunotherapy Market: Pancreatic Cancer (2017-2022) & ($ Millions)

Figure 17. T-Cell Immunotherapy in Others

Figure 18. Global T-Cell Immunotherapy Market: Others (2017-2022) & ($ Millions)

Figure 19. Global T-Cell Immunotherapy Market Size Market Share by Application in 2021

Figure 20. Global T-Cell Immunotherapy Revenue Market Share by Player in 2021

Figure 21. Global T-Cell Immunotherapy Market Size Market Share by Regions (2017-2022)

Figure 22. Americas T-Cell Immunotherapy Market Size 2017-2022 ($ Millions)

Figure 23. APAC T-Cell Immunotherapy Market Size 2017-2022 ($ Millions)

Figure 24. Europe T-Cell Immunotherapy Market Size 2017-2022 ($ Millions)

Figure 25. Middle East & Africa T-Cell Immunotherapy Market Size 2017-2022 ($ Millions)

Figure 26. Americas T-Cell Immunotherapy Value Market Share by Country in 2021

Figure 27. Americas T-Cell Immunotherapy Consumption Market Share by Type in 2021

Figure 28. Americas T-Cell Immunotherapy Market Size Market Share by Application in 2021

Figure 29. United States T-Cell Immunotherapy Market Size Growth 2017-2022 ($ Millions)

Figure 30. Canada T-Cell Immunotherapy Market Size Growth 2017-2022 ($ Millions)

Figure 31. Mexico T-Cell Immunotherapy Market Size Growth 2017-2022 ($ Millions)

Figure 32. Brazil T-Cell Immunotherapy Market Size Growth 2017-2022 ($ Millions)

Figure 33. APAC T-Cell Immunotherapy Market Size Market Share by Region in 2021

Figure 34. APAC T-Cell Immunotherapy Market Size Market Share by Application in 2021

Figure 35. China T-Cell Immunotherapy Market Size Growth 2017-2022 ($ Millions)

Figure 36. Japan T-Cell Immunotherapy Market Size Growth 2017-2022 ($ Millions)

Figure 37. Korea T-Cell Immunotherapy Market Size Growth 2017-2022 ($ Millions)

Figure 38. Southeast Asia T-Cell Immunotherapy Market Size Growth 2017-2022 ($ Millions)

Figure 39. India T-Cell Immunotherapy Market Size Growth 2017-2022 ($ Millions)

Figure 40. Australia T-Cell Immunotherapy Market Size Growth 2017-2022 ($ Millions)

Figure 41. Europe T-Cell Immunotherapy Market Size Market Share by Country in 2021

Figure 42. Europe T-Cell Immunotherapy Market Size Market Share by Type in 2021

Figure 43. Europe T-Cell Immunotherapy Market Size Market Share by Application in 2021

Figure 44. Germany T-Cell Immunotherapy Market Size Growth 2017-2022 ($ Millions)

Figure 45. France T-Cell Immunotherapy Market Size Growth 2017-2022 ($ Millions)

Figure 46. UK T-Cell Immunotherapy Market Size Growth 2017-2022 ($ Millions)

Figure 47. Italy T-Cell Immunotherapy Market Size Growth 2017-2022 ($ Millions)

Figure 48. Russia T-Cell Immunotherapy Market Size Growth 2017-2022 ($ Millions)

Figure 49. Middle East & Africa T-Cell Immunotherapy Market Size Market Share by Region in 2021

Figure 50. Middle East & Africa T-Cell Immunotherapy Market Size Market Share by Type in 2021

Figure 51. Middle East & Africa T-Cell Immunotherapy Market Size Market Share by Application in 2021

Figure 52. Egypt T-Cell Immunotherapy Market Size Growth 2017-2022 ($ Millions)

Figure 53. South Africa T-Cell Immunotherapy Market Size Growth 2017-2022 ($ Millions)

Figure 54. Israel T-Cell Immunotherapy Market Size Growth 2017-2022 ($ Millions)

Figure 55. Turkey T-Cell Immunotherapy Market Size Growth 2017-2022 ($ Millions)

Figure 56. GCC Country T-Cell Immunotherapy Market Size Growth 2017-2022 ($ Millions)

Figure 57. Americas T-Cell Immunotherapy Market Size 2023-2028 ($ Millions)

Figure 58. APAC T-Cell Immunotherapy Market Size 2023-2028 ($ Millions)

Figure 59. Europe T-Cell Immunotherapy Market Size 2023-2028 ($ Millions)

Figure 60. Middle East & Africa T-Cell Immunotherapy Market Size 2023-2028 ($ Millions)

Figure 61. United States T-Cell Immunotherapy Market Size 2023-2028 ($ Millions)

Figure 62. Canada T-Cell Immunotherapy Market Size 2023-2028 ($ Millions)

Figure 63. Mexico T-Cell Immunotherapy Market Size 2023-2028 ($ Millions)

Figure 64. Brazil T-Cell Immunotherapy Market Size 2023-2028 ($ Millions)

Figure 65. China T-Cell Immunotherapy Market Size 2023-2028 ($ Millions)

Figure 66. Japan T-Cell Immunotherapy Market Size 2023-2028 ($ Millions)

Figure 67. Korea T-Cell Immunotherapy Market Size 2023-2028 ($ Millions)

Figure 68. Southeast Asia T-Cell Immunotherapy Market Size 2023-2028 ($ Millions)

Figure 69. India T-Cell Immunotherapy Market Size 2023-2028 ($ Millions)

Figure 70. Australia T-Cell Immunotherapy Market Size 2023-2028 ($ Millions)

Figure 71. Germany T-Cell Immunotherapy Market Size 2023-2028 ($ Millions)

Figure 72. France T-Cell Immunotherapy Market Size 2023-2028 ($ Millions)

Figure 73. UK T-Cell Immunotherapy Market Size 2023-2028 ($ Millions)

Figure 74. Italy T-Cell Immunotherapy Market Size 2023-2028 ($ Millions)

Figure 75. Russia T-Cell Immunotherapy Market Size 2023-2028 ($ Millions)

Figure 76. Spain T-Cell Immunotherapy Market Size 2023-2028 ($ Millions)

Figure 77. Egypt T-Cell Immunotherapy Market Size 2023-2028 ($ Millions)

Figure 78. South Africa T-Cell Immunotherapy Market Size 2023-2028 ($ Millions)

Figure 79. Israel T-Cell Immunotherapy Market Size 2023-2028 ($ Millions)

Figure 80. Turkey T-Cell Immunotherapy Market Size 2023-2028 ($ Millions)

Figure 81. GCC Countries T-Cell Immunotherapy Market Size 2023-2028 ($ Millions)